These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15964637)

  • 1. Proteasome antibodies in paraneoplastic cerebellar degeneration.
    Storstein A; Knudsen A; Vedeler CA
    J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
    J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
    Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
    Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
    N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.
    Darnell JC; Albert ML; Darnell RB
    Cancer Res; 2000 Apr; 60(8):2136-9. PubMed ID: 10786675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spinal cord paraneoplastic syndromes].
    Marés-Segura R
    Rev Neurol; 2000 Dec 16-31; 31(12):1219-23. PubMed ID: 11205563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
    Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
    Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
    J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
    Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
    Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
    Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
    Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological advances on central nervous system paraneoplastic syndromes.
    Graus F; René R
    Rev Neurol (Paris); 1992; 148(6-7):496-501. PubMed ID: 1448670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
    Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
    J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.